Profound Medical Corp. (PROF) Tops Q2 EPS by 70c

Profound Medical Corp. (NASDAQ: PROF) reported Q2 EPS of $0.35, $0.70 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $1.61 million versus the consensus estimate of $2.13 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c